An analysis of the total tau concentration among MS patients, stratified by their clinical and radiological characteristics, unveiled a significant elevation in CSF total tau protein levels in individuals exhibiting a higher T2 LL on brain MRI. The gene discussed is MAPT; the disease is myeloid sarcoma.